Taking into account that DHFR is an important molecular target in anti-cancer therapy and CX-4945 is a potential anti-cancer agent, the significant elevation of DHFR concentration and its resulting activity increase in cells may contribute to the vast reduction in the effectiveness of treatment. This evidence concerns the gene DHFR and cancer.